Company profilePharmaceutical#482 of 1,318 in Pakistan1 DRAP alert

UNIPHARMA (PVT) LTD.

Pharmaceutical company · 29 brands · 59 molecules

Ranked #78 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

29 registered products 32 pharmaceutical brands 59 distinct molecules 1 DRAP alert

Company overview

29
registered products
32
pharmaceutical brands
59
distinct molecules
7
therapeutic classes
1
DRAP alerts

UNIPHARMA (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 29 product registrations across 59 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Endocrine Hormone Therapy. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by UNIPHARMA

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20251

Top molecules by brand count

Thiamine3 brands
Riboflavin3 brands
Folic Acid3 brands
Pyridoxine3 brands
Nicotinamide3 brands
Famotidine2 brands
Retinol2 brands
Calciferol2 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 5Endocrine Hormone Therapy · 1Other Urological · 1Ace Inhibitor · 1Vitamin B Complex Plain & With Vitamin C · 1Antianemic, Iron & All Combination · 1Calcium Channel Blockers · 1

Regulatory record

1 alert in the DRAP feed we track.

Drug Safety Alert: Increased Risk of Cardiovascular Events with Co-administration and Inte
2022-11-29

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

ENGLISH PHARMACEUTICALS INDUSTRIES holds 70 molecules not in this portfolio
000 I.UAmikacinAmoxicillinAmoxicillin BaseAmoxycillin BaseAmpicillin
Pfizer Laboratories (Pvt) Ltd. holds 131 molecules not in this portfolio
AlprazolamAluminium HydroxideAluminium Hydroxide And OxideAmlodipineAmodiaquineAmodiaquine Base
ABBOTT LABORATORIES (PAKISTAN) LIMITED. holds 114 molecules not in this portfolio
AcetylcysteineAcriflavineAcyclovirAcyclovir Inf/OralAlcoholAluminium Hydroxide

Get the full profile for UNIPHARMA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.